Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Federal research agency

Appears in 1 story

Stories

Decoding the GLP-1 weight-loss plateau

New Capabilities

Lead institution on the May 2026 Nature Metabolism study

Patients on Ozempic and Wegovy typically lose about 15% of their body weight, then stall around 14 months in. On May 25, NIH researchers in Nature Metabolism reported what may be happening inside the brain to cause that stall, and a way to keep the drug working longer.

Updated 2 hours ago